Medication nonadherence: Part II--A pilot study in patients with congestive heart failure.
Nonadherence is a significant medical problem in the United States, leading to excessive morbidity, mortality, and medical costs. In the conclusion to this two-part article, the authors describe a pilot study involving 311 patients taking an angiotensin-converting enzyme inhibitor that evaluates the principal factors for nonadherence to pharmaceutical therapy in patients with congestive heart failure.
Rodgers
P T
PT
Virginia Commonwealth University School of Pharmacy, Richmond, USA.
Ruffin
D M
DM
D000046:Academic Medical Centers; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D015897:Comorbidity; D004358:Drug Therapy / Q000523:psychology*; D004656:Enalapril / Q000008:administration & dosage*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010044:Outpatient Clinics, Hospital; D010349:Patient Compliance; D017064:Process Assessment, Health Care; D011897:Random Allocation; D018570:Risk Assessment; D014481:United States
D000806:Angiotensin-Converting Enzyme Inhibitors; D004656:Enalapril